DCM
PHGE icon

DAFNA Capital Management’s BiomX PHGE Stock Holding History

DAFNA Capital Management’s Portfolio PHGE Stock Details PHGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-21,112
Closed -$211K – 84
2025
Q3 		$211K Hold
21,112
– – 0.05% 74
2025
Q2 		$181K Hold
21,112
– – 0.05% 74
2025
Q1 		$223K Hold
21,112
– – 0.06% 79
2024
Q4 		$293K Hold
21,112
– – 0.07% 78
2024
Q3 		$409K Buy
+21,112
New +$765K 0.1% 72

Other funds holding PHGE

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return

DAFNA Capital Management's PHGE Position: Q4 2025 in Review

DAFNA Capital Management sold out of BiomX (PHGE) in Q4 2025, closing a stake of 21,112 shares — an estimated $211K sold.

DAFNA Capital Management first reported a position in PHGE in Q3 2024 and held it in 5 quarters. The position peaked at $409K in Q3 2024. 11 funds tracked by Wall St. Rank hold PHGE as of Q4 2025.

  • DAFNA Capital Management reported no remaining BiomX position as of Q4 2025 after selling out during the quarter.
  • DAFNA Capital Management sold 21,112 BiomX shares in Q4 2025, an estimated $211K.
  • DAFNA Capital Management first reported a position in BiomX in Q3 2024 and held it in 5 quarters.
  • DAFNA Capital Management's BiomX position peaked at $409K in Q3 2024.
  • 11 funds tracked by Wall St. Rank held BiomX as of Q4 2025.

Based on DAFNA Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.